Jul 2026
Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy
Among patients treated with NAC for early-stage BC, residual nodal disease, inflammatory BC, and HER2+ or triple-negative subtype are associated with a higher risk of BrM development and whether BrM screening is warranted among patients with these high-risk features warrants evaluation.
Jie Zhu, I. Fernandes, Júlia Belone Lopes et al.
· Journal of Neuro-Oncology · 0 citations